Dr. Reddy's Laboratories has launched Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial approved by the US Food and Drug Administration (USFDA).
The company’s Ertapenem for Injection, 1 g/vial, is available in packs of 10 vials per carton. The INVANZ brand and generic market had US sales of around $205 million MAT for the most recent twelve months ending in March 2021 according to IQVIA Health.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
